Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Sales | 5,639 | 4,548 | 4,822 | 4,593 | 4,531 |
| Gross Profit | 5,630 | 4,550 | 4,820 | 4,590 | 5,370 |
| Operating Expenses | 5,870 | 7,980 | 9,010 | 10,010 | 10,800 |
| Operating Income | -231 | -3,432 | -4,188 | -5,417 | -6,269 |
| Interest Expense | 360 | 440 | 420 | 300 | 260 |
| Other Income | -239 | -2,228 | -222 | -713 | 129 |
| Pre-tax Income | -830 | -6,100 | -4,830 | -6,430 | -6,400 |
| Net Income Continuous | -830 | -6,090 | -4,834 | -6,437 | -6,406 |
| Net Income | $-830 | $-6,090 | $-4,834 | $-6,437 | $-6,406 |
| EPS Basic Total Ops | -1,400.56 | -8,403.36 | -7,703.08 | -10,504.20 | -10,504.20 |
| EPS Basic Continuous Ops | -1,185.71 | -8,700.00 | -8,056.67 | -10,728.33 | -10,676.67 |
| EPS Diluted Total Ops | -1,400.56 | -8,403.36 | -7,703.08 | -10,504.20 | -10,504.20 |
| EPS Diluted Continuous Ops | -1,185.71 | -8,700.00 | -8,056.67 | -10,728.33 | -10,676.67 |
| EBITDA(a) | $539 | $-2,622 | $-3,248 | $-4,517 | $-5,309 |